NEW YORK (GenomeWeb) – Agilent Technologies announced today that it has signed a co-marketing agreement with Carlsbad, California-based Applied Spectral Imaging for fluorescent in situ hybridization (FISH) products.

Under the terms of the agreement, the firms will jointly market ASI's GenASIs imaging platforms with Agilent's FISH products, including the Dako Omnis instrument for automated sample processing. The agreement would provide pathology labs with the components to create a fully automated, end-to-end FISH workflow, the firms said in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.